Nobilis Health Corp (NRTSF)

[1center]

Nobilis Health beats by $0.04, reports revs in-line; reaffirms FY16 outlook
4:55 PM ET 8/2/16 | Briefing.com
RELATED QUOTES


4:00 PM ET 8/2/16
Symbol Last % Chg
HLTH
2.64 0.00%
Real time quote.

Reports Q2 (Jun) earnings of $0.06 per share, $0.04 better than the Capital IQ Consensus of $0.02; revenues rose 26.6% year/year to $61.9 mln vs the $62.18 mln Capital IQ Consensus. Total case volume increased by 248 cases, or 5.4%, to 4,863 in the second quarter of 2016, as compared to the same period the prior year. Revenue per case increased to $11,524 in the second quarter of 2016, as compared to $10,136 in the same period the prior year, reflecting the impact of a higher acuity case mix from the purchase of three new hospitals in 2015. The increase in total revenue and total case volume in the second quarter compared to the same quarter the prior year was due primarily to the acquisitions of three hospitals in 2015. For full year 2016, Nobilis is reiterating its original organic growth guidance of 20% for total revenues, or $275 million, and 21% for Adjusted EBITDA, or $51 million. While our pipeline remains strong, as evidenced by the recently announced agreement to acquire Arizona Vein and Vascular, the timing of acquisitions is always uncertain. Therefore, from this point forward, Nobilis will no longer provide guidance that includes acquisitions. As we close future acquisitions, including Arizona Vein and Vascular, we will provide additional guidance.